Skip to main content

Table 2 Timeline for a randomized trial evaluating fire needle therapy for blood stasis syndrome of plaque psoriasis

From: Efficacy and safety of fire needle therapy for blood stasis syndrome of plaque psoriasis: protocol for a randomized, single-blind, multicenter clinical trial

 

Research cycle

Screening period

Baseline period

Treatment period

Early termination

Follow-up period

Time point

Week 1

Week 0

Week 1

Week 2

Week 3

Week 4

Week 6

Week 8

Enrollment

Inclusion/exclusion criteria

       

Informed consent

        

Demographic characteristics

        

Medical history

        

Registration

        

Randomization

 

       

Photographs of skin lesions

 

Interventions

Basic therapy + fire needle therapy

 

-------------------------------------------------------------------

  

Basic therapy + fire needle control therapy

 

-------------------------------------------------------------------

  

Assessment

PASI

BSA

PGA

DLQI

 

  

PRQoL

 

  

VAS

 

TCM symptom

 

  

Recurrence rate

       

Safety

Vital signs

Blood routine

    

  

Blood biochemistry

    

  

Urine routine

    

  

Concomitant medication

  

Pregnancy test

        

Physical examination

    

Adverse events

 

Serious adverse events

  1. PASI Psoriasis Area and Severity Index, BSA body surface area, PGA Physician Global Assessment, DLQI Dermatology Life Quality Index, PRQoL patient-reported quality of life, VAS visual analog scale, TCM traditional Chinese medicine
  2. : Fire needle therapy group
  3. : Fire needle control therapy group